These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6108711)

  • 1. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer.
    Davies PS; Rhodes J; Counsell B; Evans BK
    Am J Gastroenterol; 1980 Aug; 74(2):150-3. PubMed ID: 6108711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.
    Riis P; Anthonisen P; Wulff HR; Folkenborg O; Bonnevie O; Binder V
    Scand J Gastroenterol; 1973; 8(1):71-4. PubMed ID: 4144533
    [No Abstract]   [Full Text] [Related]  

  • 3. Disodium cromoglycate maintenance treatment of ulcerative colitis.
    Langman MJ; Dronfield MW
    Acta Allergol; 1977; Suppl 13():76-81. PubMed ID: 24321
    [No Abstract]   [Full Text] [Related]  

  • 4. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxygen-derived free radical scavengers in the management of recurrent attacks of ulcerative colitis: a new approach.
    Salim AS
    J Lab Clin Med; 1992 Jun; 119(6):710-7. PubMed ID: 1350610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prophylactic effect of salazosulfapyridine in ulcerative colitis after a period of one year without symptoms on long-term treatment. A double-blind investigation].
    Binder V; Bonnevie O; Folkenborg O; Anthonisen P; Wulff HR; Riis P
    Ugeskr Laeger; 1972 Oct; 134(40):2093-5. PubMed ID: 4405794
    [No Abstract]   [Full Text] [Related]  

  • 9. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
    Goenka MK; Kochhar R; Tandia B; Mehta SK
    Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis.
    Gilat T; Leichtman G; Delpre G; Eshchar J; Bar Meir S; Fireman Z
    J Clin Gastroenterol; 1989 Aug; 11(4):392-5. PubMed ID: 2569488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
    Musch E; Andus T; Malek M; Chrissafidou A; Schulz M
    Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter study.
    Nilsson A; Danielsson A; Löfberg R; Benno P; Bergman L; Fausa O; Florholmen J; Karvonen AL; Kildebo S; Kollberg B
    Am J Gastroenterol; 1995 Mar; 90(3):381-7. PubMed ID: 7872274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical response to heparin in 10 patients with ulcerative colitis.
    Gaffney PR; Doyle CT; Gaffney A; Hogan J; Hayes DP; Annis P
    Am J Gastroenterol; 1995 Feb; 90(2):220-3. PubMed ID: 7847289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.
    Kruis W; Judmaier G; Kayasseh L; Stolte M; Theuer D; Scheurlen C; Hentschel E; Kratochvil P
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):391-6. PubMed ID: 7614099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
    Paoluzi OA; Iacopini F; Pica R; Crispino P; Marcheggiano A; Consolazio A; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2005 May; 21(9):1111-9. PubMed ID: 15854173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcerative colitis in Thailand: a clinical study and long term follow-up.
    Pongprasobchai S; Manatsathit S; Leelakusolvong S; Sattawatthamrong Y; Boonyapisit S
    J Med Assoc Thai; 2001 Sep; 84(9):1281-8. PubMed ID: 11800302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.